These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7843201)

  • 1. Intracerebral haemorrhages in surfactant treated neonates with severe respiratory distress syndrome: age at diagnosis, severity and risk factors.
    Herting E; Gefeller O; Speer CP; Harms K; Halliday HL; Curstedt T; Robertson B
    Eur J Pediatr; 1994 Nov; 153(11):842-9. PubMed ID: 7843201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing morbidity and mortality in infants with severe respiratory distress syndrome treated with single or multiple doses of a natural porcine surfactant.
    Herting E; Speer CP; Harms K; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; McClure G; Reid M
    Biol Neonate; 1992; 61 Suppl 1():26-30. PubMed ID: 1391262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group.
    Bevilacqua G; Halliday H; Parmigiani S; Robertson B
    J Perinat Med; 1993; 21(5):329-40. PubMed ID: 8126628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial.
    Bevilacqua G; Parmigiani S; Robertson B
    J Perinat Med; 1996; 24(6):609-20. PubMed ID: 9120744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
    Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
    Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
    Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
    Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of surfactant dosing via a dual-lumen endotracheal tube in respiratory distress syndrome. The Spanish Surfactant Collaborative Group.
    Valls-i-Soler A; Fernández-Ruanova B; López-Heredia y Goya J; Román Etxebarría L; Rodriguez-Soriano J; Carretero V
    Pediatrics; 1998 Apr; 101(4):E4. PubMed ID: 9533371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome].
    Herting E; Tubman R; Halliday HL; Harms K; Speer CP; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):721-7. PubMed ID: 8413348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
    Lamboley-Gilmert G; Lacaze-Masmonteil T;
    Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.
    Rebello CM; Precioso AR; Mascaretti RS;
    Einstein (Sao Paulo); 2014; 12(4):397-404. PubMed ID: 25628188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
    Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
    Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of treating neonates with surfactants for respiratory distress syndrome. I. Importance of gas exchange].
    Gadzinowski J; Szymankiewicz M; Twarowska I; Halliday H
    Ginekol Pol; 1992; 63(3):101-4. PubMed ID: 1303908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Robertson B; Curstedt T; Tubman R; Strayer D; Berggren P; Kok J; Koppe J; van Sonderen L; Halliday H; McClure G
    Eur J Pediatr; 1992 May; 151(5):372-6. PubMed ID: 1396894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
    Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
    Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.